Parkinson's Life

Interviews

Dr Maria De León on breaking down barriers in treatment and research
READ MORE
PD in Practice

Dr Fay Horak explains why people with Parkinson’s get shuffling feet
READ MORE
Global update

This month’s top Parkinson’s news stories from around the globe
READ MORE

Maria De Leon standing in front of 'Latino Victory' poster

“I struggled to find material about Parkinson’s in Spanish”

Dr Maria De León on breaking down barriers in treatment and research

Shuffling gait: is it Parkinson’s?

Dr Fay Horak explains why people with Parkinson’s get shuffling feet

Dance craze turned Parkinson’s app: the story behind Patana AI

The app helps diagnose people with Parkinson’s

Podcast roundup: conversations on the reality of Parkinson’s

A roundup of the Parkinson’s Life podcast

Tired young teacher sitting by desk in classroom and touching nose bridge

Study finds people with Parkinson’s leave work five years after diagnosis

Fatigue was cited as the biggest reason for being unable to work

Parkinson’s in the news: July

This month’s top Parkinson’s news stories from around the globe

Load more recent articles

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

A new study suggests that regular use of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may lower the risk of Parkinson’s associated with mutations of the LRRK2 gene – a common genetic cause of the condition. As part of the study, researchers analysed the data for 577 individuals with the LRRK2 gene mutation. They found that regular use of aspirin and ibuprofen – at least two pills per week for at least six months – was more prevalent in people who did not have Parkinson’s compared to those with the condition. Across the study, the use of NSAIDs corresponded with roughly a 66% decrease in the risk of Parkinson’s. The researchers say that “the results of this study suggest that the regular use of NSAID medication may lower the risk for Parkinson’s among LRRK2 variant carriers … for both ibuprofen and aspirin” but more research will need to be…

US hospital initiative improves on-time administration of Parkinson’s medication

Late or missed doses of Parkinson’s medication in hospitals can lead to longer stays and greater morbidity. To counteract this issue, a team of healthcare professionals in the US launched a project to improve the on-time administration of levodopa to people with Parkinson’s. As part of the initiative – published in the Journal of Parkinson’s Disease – several measures were implemented, including electronic alerts for nurses, stocking automated medication dispensing machines with carbidopa-levodopa products, reporting to nurse unit managers on timeliness of medication administration and more. Dr Martha A Nance, the project’s lead investigator, said: “This project was very rewarding for our team, because of its obvious, immediate, and important impact on patient care. “We have reason to think that timely administration of carbidopa-levodopa may be associated with shorter stays and better outcomes and satisfaction. Anecdotally, patients have reported being surprised and pleased that nurses were reminding them that medication…

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

Researchers in France have found that deep brain stimulation for Parkinson’s may not increase the risk of developing dementia. As part of the study – published by the American Academy of Neurology – researchers identified 175 people with Parkinson’s and an average age of 56, who had deep brain stimulation. The individuals were assessed over a period of 10 years to determine if they had developed dementia. After one year, four individuals had developed dementia. After five years, 142 people from the original group were available for testing, 12 of whom had dementia. After 10 years, 104 people were available for testing, 31 of whom had dementia. Dr Elena Moro, author of the study, said: “These results are very encouraging for people with Parkinson’s and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

HOME

“I struggled to find material about Parkinson’s in Spanish”

Shuffling gait: is it Parkinson’s?

Parkinson’s in the news: July

Interviews

PD in Practice

Global update

Interviews

“I struggled to find material about Parkinson’s in Spanish”

PD in Practice

Shuffling gait: is it Parkinson’s?

Interviews

Dance craze turned Parkinson’s app: the story behind Patana AI

Episodes

Podcast roundup: conversations on the reality of Parkinson’s

PD in Practice

Study finds people with Parkinson’s leave work five years after diagnosis

Global update

Parkinson’s in the news: July

{categories}

{title}

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

US hospital initiative improves on-time administration of Parkinson’s medication

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

{title}

Subscribe

“I struggled to find material about Parkinson’s in Spanish”

Shuffling gait: is it Parkinson’s?

Parkinson’s in the news: July

Interviews

PD in Practice

Global update

Interviews

“I struggled to find material about Parkinson’s in Spanish”

PD in Practice

Shuffling gait: is it Parkinson’s?

Interviews

Dance craze turned Parkinson’s app: the story behind Patana AI

Episodes

Podcast roundup: conversations on the reality of Parkinson’s

PD in Practice

Study finds people with Parkinson’s leave work five years after diagnosis

Global update

Parkinson’s in the news: July

{categories}

{title}

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

US hospital initiative improves on-time administration of Parkinson’s medication

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

{title}

Subscribe

Sign in

Want the latest Parkinson’s Life news and content delivered straight to your inbox? Subscribe here!